Myeloma presently accounts for almost 10% of all hematologic malignancies and 1% of cancer deaths in Western countries. Although myeloma is a rare malignancy, there is relatively high mortality, with a five-year survival of 28%. This chapter reviews the epidemiology of myeloma. Topics covered include classification, incidence and mortality, host factors, and environmental factors.
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.